Extension Study of AGT-181-102 to Evaluate Long Term Safety and Activity of AGT-181

Clinical trial NCT02597114 · COMPLETED

Trial details

NCT number: NCT02597114
Sponsor: ArmaGen, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mucopolysaccharidosis I

Start date: 2015-11-01
Primary completion: 2018-03-19
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.